Clinically significant macular edema and survival in type 1 and type 2 diabetes.
about
Insulin use and risk of diabetic macular edema in diabetes mellitus: a systemic review and meta-analysis of observational studiesCurrent perspectives on ranibizumabCost-effectiveness of ranibizumab in treatment of diabetic macular oedema (DME) causing visual impairment: evidence from the RESTORE trial.Impact of data from recent clinical trials on strategies for treating patients with type 2 diabetes mellitus.Current treatments in diabetic macular oedema: systematic review and meta-analysisAnti-vascular endothelial growth factor therapy for diabetic macular edemaPharmacokinetic evaluation of pegaptanib octasodium for the treatment of diabetic edema.Prediction, by retinal location, of the onset of diabetic edema in patients with nonproliferative diabetic retinopathy.Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema.Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema.Inhibition of EGF signaling protects the diabetic retina from insulin-induced vascular leakage.The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: the twenty-five-year incidence of macular edema in persons with type 1 diabetes.Diabetic Retinopathy Clinical Practice Guidelines: Customized for Iranian Population.Comparison of time- and spectral-domain optical coherence tomography in management of diabetic macular edema.Fully Automated Robust System to Detect Retinal Edema, Central Serous Chorioretinopathy, and Age Related Macular Degeneration from Optical Coherence Tomography Images.
P2860
Q27010850-29F23DC7-AA09-452C-A6DA-4D7074375CA6Q28082383-BBD2035B-3F90-44D2-B7AF-42D5BA7877F2Q31049802-EAE17454-44C7-4831-90C7-16EA5D16B9E5Q33535235-E212CCA1-D766-4F04-A82A-73E73B0E1E74Q34606190-C64456FD-D17A-4299-A07F-073C0B6F1BE1Q35064343-79AE8EB0-FD10-423D-BA64-782DE1C23447Q35173079-E9B43F0B-38A6-4317-B149-A6B513EDA3A3Q35221188-FCF7A960-3123-4ED9-8D97-A52C8F3B6351Q36391018-339E095C-AC85-43E1-8884-A6DE355366CFQ36796899-3F6FF273-05D5-4A0A-9C26-16377C8241A6Q37149040-D80C9D3A-C0E9-4EB2-A46C-ACE1F5EE3233Q37218851-CFC17165-CEEB-4036-A089-4520998D55E1Q37477129-D88AABF9-1A60-4A76-8BC5-4F18B690949EQ37623605-51300176-CD35-4F94-A2B6-E0D36445393BQ37739328-C9B69B83-3BBE-4845-B224-B0615D67FD57
P2860
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@ast
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@en
type
label
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@ast
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@en
prefLabel
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@ast
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@en
P2860
P1476
Clinically significant macular edema and survival in type 1 and type 2 diabetes.
@en
P2093
Barbara E K Klein
Michael D Knudtson
P2860
P304
P356
10.1016/J.AJO.2007.11.019
P407
P577
2008-01-28T00:00:00Z